134677-60-4 Usage
Uses
Used in Pharmaceutical Research and Development:
Carbamic acid, (1alpha,5alpha,6beta)-3-azabicyclo[3.1.0]hex-6-yl-, 1,1-dimethylethyl ester is used as an intermediate in pharmaceutical research and development for its potential applications in the synthesis of various pharmaceutical compounds. Its unique chemical structure and properties make it a valuable building block in the development of new drugs and therapeutic agents.
Used in Organic Synthesis:
In the field of organic synthesis, Carbamic acid, (1alpha,5alpha,6beta)-3-azabicyclo[3.1.0]hex-6-yl-, 1,1-dimethylethyl ester serves as a key intermediate in the synthesis of various organic compounds. Its versatility and reactivity make it a valuable component in the preparation of complex organic molecules, including pharmaceuticals, agrochemicals, and other specialty chemicals.
Check Digit Verification of cas no
The CAS Registry Mumber 134677-60-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,4,6,7 and 7 respectively; the second part has 2 digits, 6 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 134677-60:
(8*1)+(7*3)+(6*4)+(5*6)+(4*7)+(3*7)+(2*6)+(1*0)=144
144 % 10 = 4
So 134677-60-4 is a valid CAS Registry Number.
134677-60-4Relevant academic research and scientific papers
6-(3-AZA-BICYCLO[3.1.0]HEX-3-YL)-2-PHENYL-PYRIMIDINES
-
Page/Page column 49, (2010/11/03)
The present invention relates to 6-(3-aza-bicyclo[3.1.0]hex-3-yl)-2-phenyl-pyrimidine derivatives and their use as P2Y12 receptor antagonists in the treatment and/or prevention of peripheral vascular, of visceral-, hepatic- and renal-vascular, of cardiovascular and of cerebrovascular diseases or conditions associated with platelet aggregation, including thrombosis in humans and other mammals.
Conformational constraint in oxazolidinone antibacterials. Synthesis and structure-activity studies of (azabicyclo[3.1.0]hexylphenyl)oxazolidinones
Renslo, Adam R.,Jaishankar, Priyadarshini,Venkatachalam, Revathy,Hackbarth, Corinne,Lopez, Sara,Patel, Dinesh V.,Gordeev, Mikhail F.
, p. 5009 - 5024 (2007/10/03)
The oxazolidinones are a new class of synthetic antibacterials effective against a broad range of pathogenic Gram-positive bacteria, including multi-drug-resistant strains. Linezolid is the first drug from this class to reach the market and has become an
